News

AFAR's 5th AI Meetup: our synthetic doctors, presented with Idorsia

On November 17, the AI and Health working group of AFAR, the French regulatory affairs association, held its 5th AI Meetup in front of 178 attendees. Yassine Belfkih, CEO of Engramm, and Alexandra Scoazec-Guerton of Idorsia presented the synthetic doctors that the company's medical sales reps and MSLs practice with.

Yassine Belfkih and Alexandra Scoazec-Guerton on stage, in front of a slide titled “What AI brings, what it doesn't replace” (in French), at AFAR's 5th AI Meetup.

Yassine Belfkih (Engramm) and Alexandra Scoazec-Guerton (Idorsia) during their talk, on November 17. The slides were in French.

Date
November 17, 2026, evening, in French
Host
AFAR's AI and Health working group
Speakers
Yassine Belfkih (Engramm) and Alexandra Scoazec-Guerton (Idorsia), among seven speakers
Audience
178 attendees from regulatory affairs, pharmacovigilance and compliance

An evening on AI in regulatory affairs.

AFAR (Association française des affaires réglementaires) has an AI and Health working group that runs these evenings, so that pharmaceutical companies and vendors can show what they do with AI. There were seven speakers that night.

Julien Samson (Cerba Healthcare) and Matthieu Filet (2PACE) presented AI agents for pharmacovigilance and medical information. Sylvain Bihan and Sophie Rieu showed how UCB uses AI at each step of the compliance review of a promotional document. For Thomas Desportes (Chugai Pharma), an AI tool has to be “useful, usable and used.”

Maria Milla-Delcroix, an interim executive in regulatory affairs and pharmacovigilance, posted a recap of the evening on LinkedIn, in French. According to the recap, the room was unanimous on one point: answering a health authority or validating a safety signal is still a decision that a person makes and signs.

Between training and the field visit.

Our talk started from one question: “The teams have heard the message, but are they ready to deliver it in the field?”

On a visit, a pharmaceutical sales rep has to present the message approved by the company, stay within the marketing authorization and the summary of product characteristics (SmPC), and give the safety information. Companies run a lot of training seminars, but between sessions reps rarely practice on their own, and managers can't join every visit. Meanwhile, part of what was learned is forgotten, as the forgetting curve shows.

Practicing with synthetic doctors.

A synthetic doctor is a physician played by AI. The rep runs the visit out loud. You choose the doctor's profile, for example a conservative physician or a high prescriber, and how hard the doctor is to convince. The doctor asks questions and raises objections.

At the end, the scorecard shows whether the expected messages came across (indication, patient populations, dosage) and whether the rep stayed scientifically accurate. It also measures talk time and monologues. The AI coach then goes over what was missing with the rep.

At Idorsia, medical sales reps and some MSLs have used Engramm since March 2026, on a voluntary basis. Reps use it to prepare their visits. MSLs work on the scientific accuracy of their answers, and practice in English before international congresses. Scenarios and rubrics are based on the SmPCs, the studies and materials that have already been approved. Our page on pharma sales training shows other scenarios for pharmaceutical companies.

What stays with the teams.

One slide of the talk, the one in the photo, listed it (translated from French).

What AI bringsWhat it doesn't replace
Repetition, on demandThe trainer and the manager
A range of profiles and situationsReading body language
The right to try, with no one watchingThe unexpected in a real visit
Practice in several languagesMedical sign-off on the content

At Idorsia, reps then go over their results with their manager during joint field visits. The content used in Engramm is approved by the company's medical and regulatory teams. Our guide AI coach vs. human coach looks at how the work is split between AI and managers.

Thanks to Edouard Lechaptois, Florent Lunet and Laurent Clerc for organizing the evening, and to Alexandra Scoazec-Guerton for sharing Idorsia's experience.

Geoffrey Mathern

Director of Operations, Engramm

Geoffrey Mathern has been Director of Operations at Engramm since October 2025. He works with the training teams and sales leaders of Engramm's customers, from scenario design to tracking results. Before Engramm, he spent more than ten years in digital marketing and SEO, including almost six at Fabernovel.

LinkedIn profile
Newsletter

Get the next resources.

An email every two weeks with new guides, customer stories and webinars.

See Engramm on one of your topics.

In 45 minutes, we show you the platform on a topic your teams work on.

Book a demo
Book a demo